Reanalysing genomic data by normalized coverage values uncovers CNVs in bone marrow failure gene panels.

Genetic testing Medical genomics

Journal

NPJ genomic medicine
ISSN: 2056-7944
Titre abrégé: NPJ Genom Med
Pays: England
ID NLM: 101685193

Informations de publication

Date de publication:
2019
Historique:
received: 19 10 2018
accepted: 04 10 2019
entrez: 17 12 2019
pubmed: 17 12 2019
medline: 17 12 2019
Statut: epublish

Résumé

Inherited bone marrow failure syndromes (IBMFSs) are genetically heterogeneous disorders with cytopenia. Many IBMFSs also feature physical malformations and an increased risk of cancer. Point mutations can be identified in about half of patients. Copy number variation (CNVs) have been reported; however, the frequency and spectrum of CNVs are unknown. Unfortunately, current genome-wide methods have major limitations since they may miss small CNVs or may have low sensitivity due to low read depths. Herein, we aimed to determine whether reanalysis of NGS panel data by normalized coverage value could identify CNVs and characterize them. To address this aim, DNA from IBMFS patients was analyzed by a NGS panel assay of known IBMFS genes. After analysis for point mutations, heterozygous and homozygous CNVs were searched by normalized read coverage ratios and specific thresholds. Of the 258 tested patients, 91 were found to have pathogenic point variants. NGS sample data from 165 patients without pathogenic point mutations were re-analyzed for CNVs; 10 patients were found to have deletions. Diamond Blackfan anemia genes most commonly exhibited heterozygous deletions, and included

Identifiants

pubmed: 31839986
doi: 10.1038/s41525-019-0104-9
pii: 104
pmc: PMC6901453
doi:

Types de publication

Journal Article

Langues

eng

Pagination

30

Informations de copyright

© The Author(s) 2019.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing interests.

Références

Bioinformatics. 2012 Nov 1;28(21):2747-54
pubmed: 22942019
Pediatrics. 2008 Jul;122(1):e139-48
pubmed: 18595958
Semin Hematol. 2011 Apr;48(2):124-35
pubmed: 21435509
Nature. 2008 Oct 16;455(7215):919-23
pubmed: 18923514
Hematology. 2015 Aug;20(7):433-4
pubmed: 26218202
Blood Rev. 2010 May;24(3):101-22
pubmed: 20417588
J Am Acad Child Adolesc Psychiatry. 2013 Aug;52(8):772-4
pubmed: 23880486
Haematologica. 2015 Jan;100(1):42-8
pubmed: 25239263
Br J Haematol. 2017 May;177(4):526-542
pubmed: 28211564
Am J Hum Genet. 1999 Nov;65(5):1330-41
pubmed: 10521298
Blood. 2017 Mar 16;129(11):1557-1562
pubmed: 28062395
Genome Biol. 2010;11(10):R106
pubmed: 20979621
J Med Genet. 2015 Sep;52(9):575-84
pubmed: 26136524
J Med Genet. 2011 Sep;48(9):618-28
pubmed: 21659346
J Med Genet. 2015 Nov;52(11):738-48
pubmed: 26342108
Nucleic Acids Res. 2014 Jan;42(Database issue):D986-92
pubmed: 24174537
Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R57-66
pubmed: 16651370
Haematologica. 2016 Nov;101(11):1275-1276
pubmed: 27799343
Mol Genet Genomic Med. 2015 Jul 02;3(6):500-12
pubmed: 26740942
Blood. 2012 Mar 8;119(10):2376-84
pubmed: 22262766
Am J Hum Genet. 2018 Jan 4;102(1):142-155
pubmed: 29304372
NPJ Genom Med. 2017 May 10;2:
pubmed: 28690869
Expert Rev Mol Med. 2010 Mar 09;12:e8
pubmed: 20211047

Auteurs

Supanun Lauhasurayotin (S)

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON Canada.
2Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON Canada.

Geoff D Cuvelier (GD)

3Pediatric Hematology-Oncology-Bone Marrow Transplantation, University of Manitoba, Cancer Care Manitoba, Winnipeg, MB Canada.

Robert J Klaassen (RJ)

4Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, ON Canada.

Conrad V Fernandez (CV)

5Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS Canada.

Yves D Pastore (YD)

6CHU Sainte-Justine, Montreal, QC Canada.

Sharon Abish (S)

7Pediatric Hematology Oncology, Montreal Children's Hospital, Montreal, QC Canada.

Meera Rayar (M)

8Division of Hematology/Oncology, UBC & B.C. Children's Hospital, Vancouver, BC Canada.

MacGregor Steele (M)

9Alberta Children's Hospital, Calgary, Canada.

Lawrence Jardine (L)

10Children's Hospital, London Health Sciences Centre, London, ON Canada.

Vicky R Breakey (VR)

11Department of Pediatrics, McMaster University, Hamilton, ON Canada.

Josee Brossard (J)

12Centre hospitalier universitaire, Sherbrooke, QC Canada.

Roona Sinha (R)

13Royal University Hospital, Saskatoon, SK Canada.

Mariana Silva (M)

14Kingston General Hospital, Kingston, ON Canada.

Lisa Goodyear (L)

15Pediatric Hematology/Oncology, Janeway Child Health Centre, St. John's, NF Canada.

Jeffrey H Lipton (JH)

16Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON Canada.

Bruno Michon (B)

17Centre Hospitalier Universitaire de Quebec, Sainte-Foy, QC Canada.

Catherine Corriveau-Bourque (C)

18Pediatrics, University of Alberta, Edmonton, AB Canada.

Lillian Sung (L)

19Population Health Sciences, Research Institute, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON Canada.

Iren Shabanova (I)

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON Canada.

Hongbing Li (H)

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON Canada.

Bozana Zlateska (B)

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON Canada.

Santhosh Dhanraj (S)

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON Canada.
20Institute of Medical Science, University of Toronto, Toronto, ON Canada.

Michaela Cada (M)

2Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON Canada.

Stephen W Scherer (SW)

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON Canada.
21McLaughlin Centre and Department of Molecular Genetics, University of Toronto, Toronto, ON Canada.

Yigal Dror (Y)

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON Canada.
2Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON Canada.
20Institute of Medical Science, University of Toronto, Toronto, ON Canada.

Classifications MeSH